HUTCHMED (China) Ltd (STU:H7T1)
€ 16.1 0.5 (3.21%) Market Cap: 2.75 Bil Enterprise Value: 2.08 Bil PE Ratio: 0 PB Ratio: 4.11 GF Score: 64/100

HUTCHMED (China) Ltd at Goldman Sachs Healthcare Conference Transcript

Jun 12, 2023 / 03:00PM GMT
Release Date Price: €10.7 (-1.83%)
Paul Choi
Goldman Sachs Group, Inc., Research Division - Equity Analyst

Good morning, everyone. I'm Paul Choi, and I cover the U.S. biotechnology sector here at Goldman Sachs, and it's our pleasure to welcome you those are here and online to our conference. Before we begin, we are required to make certain disclosures in public appearances about Goldman Sachs' relationship with the companies that we discuss.

Disclosures relate to investment banking relationships, compensation received or 1% or more ownership. We are prepared to read aloud disclosures for any issuer during the sessions upon your request. However, these disclosures are available in our most recent reports available to U.S. clients on our firm's portal. In addition, updates to these disclosures are available by ticker on the firm's public website at https://www.gs.com/research/hedge.html.

Goldman Sachs agrees to host this conference on the basis that no third-party speaker will provide confidential or material nonpublic information. In addition

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot